Riboviria
Riboviria is a realm of viruses that includes all viruses that use RNA as their genetic material. This realm was established by the International Committee on Taxonomy of Viruses (ICTV) in 2018. The name "Riboviria" is derived from the Latin ribo, meaning "ribonucleic acid", and viria, meaning "viruses".
Taxonomy[edit]
The realm Riboviria is divided into two kingdoms: Orthornavirae and Pararnavirae. These kingdoms are further divided into phyla, classes, orders, families, genera, and species. The classification of viruses within Riboviria is based on their genome structure and replication mechanisms.
Characteristics[edit]
Viruses in the realm Riboviria have RNA genomes that can be either single-stranded or double-stranded. The RNA genome is used to synthesize proteins and to replicate the virus. Riboviria viruses can infect a wide range of hosts, including bacteria, archaea, plants, animals, and fungi.
Replication[edit]
The replication of Riboviria viruses involves the transcription of the RNA genome into a complementary RNA strand, which is then used as a template for the synthesis of new RNA genomes. This process is carried out by the virus's own RNA-dependent RNA polymerase (RdRp).
Pathogenicity[edit]
Many viruses in the realm Riboviria are pathogenic, causing diseases in their hosts. These include some of the most well-known and deadly viruses, such as HIV, influenza, Ebola, and SARS-CoV-2, the virus that causes COVID-19.
See also[edit]
References[edit]
Riboviria gallery[edit]
-
Riboviria collage
-
Pone.0139001.g001
-
Novel Coronavirus SARS-CoV-2
-
Tobacco Mosaic Virus
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
